HELIUS MEDICAL TECHNOLOGIES, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Helius Medical Technologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2016 to Q4 2023.
  • Helius Medical Technologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $37.6M, a 11.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $37.6M +$3.81M +11.3% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $33.8M +$2.55M +8.16% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $31.2M +$3.05M +10.8% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $28.2M +$3.39M +13.7% Dec 31, 2020 10-K 2022-03-14
Q4 2019 $24.8M +$6.01M +32% Dec 31, 2019 10-K 2021-03-10
Q4 2018 $18.8M +$4.21M +28.9% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $14.6M +$4.35M +42.5% Dec 31, 2017 10-K 2019-03-14
Q4 2016 $10.2M Dec 31, 2016 10-K 2018-03-12
Q1 2016 $7.25M Mar 31, 2016 10-KT 2017-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.